Yulin Ren

Dr. Yulin Ren

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2019 in Planta Medica
Verified
Journal Article
Closed access
PDF file
YRYulin Ren
Yulin Ren
AKA. Douglas Kinghorn
A. Douglas Kinghorn
Triterpenoids are distributed widely in higher plants and are of interest because of their structural diversity and broad range of bioactivities. In particular, there is a very large literature on the propensity of a variety of triterpenoids to act as potential anticancer agents. In the present review, the anticancer potential is summarized for naturally occurring triterpenoids and their semi-synthetic derivatives, including examples of lupane-, oleanane-, ursane-, and cucurbitane-type pentacyclic triterpenoids, along with dammarane-type tetracyclic triterpenes including ginsenosides and their sapogenins and dichapetalins, which have been characterized as antitumor leads from higher plants. Preliminary structure-activity relationships and reported mechanisms of the antineoplastic-related activity are included. Prior studies for triterpenoids of plant origin are supportive of additional work being conducted on the more detailed biological and mechanistic evaluation for the progression of this type of natural products as possible cancer chemotherapeutic agents. * Dedicated to Professor Dr. Cosimo Pizza in recognition of his important contributions to natural product research on the occasion of his 70th birthday in 2019.

13 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
YRYulin Ren
Yulin Ren
TFTyler Frank
Tyler Frank
GMGunnar Meyer
Gunnar Meyer
JLJizhou Lei
Jizhou Lei
JGJessica R. Grebenc
Jessica R. Grebenc
AKA. Douglas Kinghorn
A. Douglas Kinghorn
Aronia berry (black chokeberry) is a shrub native to North America, of which the fresh fruits are used in the food industry to produce different types of dietary products. The fruits of Aronia melanocarpa (Aronia berries) have been found to show multiple bioactivities potentially beneficial to human health, including antidiabetic, anti-infective, antineoplastic, antiobesity, and antioxidant activities, as well as heart-, liver-, and neuroprotective effects. Thus far, phenolic compounds, such as anthocyanins, cyanidins, phenolic acids, proanthocyanidins, triterpenoids, and their analogues have been identified as the major active components of Aronia berries. These natural products possess potent antioxidant activity, which contributes to the majority of the other bioactivities observed for Aronia berries. The chemical components and the potential pharmaceutical or health-promoting effects of Aronia berries have been summarized previously. The present review article focuses on the molecular targets of extracts of Aronia berries and the examples of promising lead compounds isolated from these berries, including cyanidin-3-O-galactoside, chlorogenic acid, quercetin, and ursolic acid. In addition, presented herein are clinical trial investigations for Aronia berries and their major components, including cancer clinical trials for chlorogenic acid and COVID-19 trial studies for quercetin. Additionally, the possible development of Aronia berries and their secondary metabolites as potential therapeutic agents is discussed. It is hoped that this contribution will help stimulate future investigations on Aronia berries for the continual improvement of human health.

8 December 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YRYulin Ren
Yulin Ren
AKA. Douglas Kinghorn
A. Douglas Kinghorn

4 March 2019 in Journal of Natural Products
Verified
Journal Article
Closed access
YRYulin Ren
Yulin Ren
EBEsperanza J. Carcache de Blanco
Esperanza J. Carcache de Blanco
JFJames R. Fuchs
James R. Fuchs
DSDjaja D. Soejarto
Djaja D. Soejarto
JBJoanna E. Burdette
Joanna E. Burdette
AKA. Douglas Kinghorn
A. Douglas Kinghorn

1 August 2018 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
YRYulin Ren
Yulin Ren
GAGerardo D. Anaya-Eugenio
Gerardo D. Anaya-Eugenio
ACAustin A. Czarnecki
Austin A. Czarnecki
TNTran Ngoc Ninh
Tran Ngoc Ninh
CYChunhua Yuan
Chunhua Yuan
AKA. Douglas Kinghorn
A. Douglas Kinghorn

5 October 2024 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
YRYulin Ren
Yulin Ren
AAAndrew T. Anderson
Andrew T. Anderson
GMGunnar Meyer
Gunnar Meyer
KLKaitlyn M. Lauber
Kaitlyn M. Lauber
JGJudith C. Gallucci
Judith C. Gallucci
AKA. Douglas Kinghorn
A. Douglas Kinghorn